Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02977689
Title Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors New York University School of Medicine
Indications

high grade glioma

Therapies

IDH305

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field